Polypill to fight cardiovascular disease - Cost effectiveness of statins for primary prevention of cardiovascular events is questionable

被引：3
|
作者：
Messori, A [1 ]
Santarlasci, B [1 ]
Trippoli, S [1 ]
Vaiani, M [1 ]
机构：
[1] Careggi Hosp, Pharmaceut Serv, Lab Farmacoecon, I-50134 Florence, Italy
来源：
BRITISH MEDICAL JOURNAL | 2003年 / 327卷 / 7418期
关键词：
D O I：
10.1136/bmj.327.7418.808-c
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：808 / 809
页数：2
相关论文
共 50 条
  • [1] The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
    van Gils, Paul F.
    Over, Eelco A. B.
    Hamberg-van Reenen, Heleen H.
    de Wit, G. Ardine
    van den Berg, Matthijs
    Schuit, Albertine J.
    Engelfriet, Peter M.
    [J]. BMJ OPEN, 2011, 1 (02):
  • [2] THE POLYPILL IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: COST-EFFECTIVENESS IN THE DUTCH POPULATION
    Van Gils, P. F.
    Hamberg-Van Reenen, H. H.
    Over, E.
    de Wit, G. A.
    van den Berg, M.
    Schuit, A. J.
    Engelfriet, P. M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A381 - A381
  • [3] Statins alone or polypill for primary prevention of cardiovascular diseases
    Hasani-Ranjbar, Shirin
    Ejtahed, Hanieh-Sadat
    [J]. JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2016, 15
  • [4] Statins alone or polypill for primary prevention of cardiovascular diseases
    Shirin Hasani-Ranjbar
    Hanieh-Sadat Ejtahed
    [J]. Journal of Diabetes & Metabolic Disorders, 15 (1):
  • [5] The polypill in the primary prevention of cardiovascular disease
    Wald, David S.
    Wald, Nicholas J.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 (01) : 29 - 35
  • [6] Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease
    Erickson, Kevin F.
    Japa, Sohan
    Owens, Douglas K.
    Chertow, Glenn M.
    Garber, Alan M.
    Goldhaber-Fiebert, Jeremy D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (12) : 1250 - 1258
  • [7] Statins and primary prevention of cardiovascular events
    Donner-Banzhoff, Norbert
    Soennichsen, Andreas
    [J]. BRITISH MEDICAL JOURNAL, 2008, 337
  • [8] Statins and the primary prevention of cardiovascular events
    Clearfield M.
    [J]. Current Atherosclerosis Reports, 2006, 8 (5) : 390 - 396
  • [9] Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease
    Ferket, Bart S.
    Hunink, M. G. Myriam
    Khanji, Mohammed
    Agarwal, Isha
    Fleischmann, Kirsten E.
    Petersen, Steffen E.
    [J]. HEART, 2017, 103 (07) : 491 - 499
  • [10] Statins for the primary prevention of cardiovascular disease
    Ebrahim, Shah
    Taylor, Fiona C.
    Brindle, Peter
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
12345